UA86565C2 - Универсальная биологическая мазь, способ лечения ожоговых ран и способ лечения химических ожогов пищевода - Google Patents
Универсальная биологическая мазь, способ лечения ожоговых ран и способ лечения химических ожогов пищевода Download PDFInfo
- Publication number
- UA86565C2 UA86565C2 UAA200815278A UAA200815278A UA86565C2 UA 86565 C2 UA86565 C2 UA 86565C2 UA A200815278 A UAA200815278 A UA A200815278A UA A200815278 A UAA200815278 A UA A200815278A UA 86565 C2 UA86565 C2 UA 86565C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- ointment
- wounds
- oesophagus
- wound
- Prior art date
Links
- 208000027418 Wounds and injury Diseases 0.000 title abstract description 43
- 206010052428 Wound Diseases 0.000 title abstract description 42
- 239000002674 ointment Substances 0.000 title abstract description 38
- 238000011282 treatment Methods 0.000 title abstract description 35
- 238000000034 method Methods 0.000 title abstract description 15
- 208000018380 Chemical injury Diseases 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 8
- 230000003628 erosive effect Effects 0.000 abstract description 3
- 230000004807 localization Effects 0.000 abstract description 3
- 238000001356 surgical procedure Methods 0.000 abstract description 3
- 208000025865 Ulcer Diseases 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 231100000397 ulcer Toxicity 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010007882 Cellulitis Diseases 0.000 abstract 1
- 208000007882 Gastritis Diseases 0.000 abstract 1
- 206010017865 Gastritis erosive Diseases 0.000 abstract 1
- 208000004210 Pressure Ulcer Diseases 0.000 abstract 1
- 206010072170 Skin wound Diseases 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 210000004087 cornea Anatomy 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 210000001331 nose Anatomy 0.000 abstract 1
- 210000003695 paranasal sinus Anatomy 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 235000013871 bee wax Nutrition 0.000 description 6
- 239000012166 beeswax Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 241000241413 Propolis Species 0.000 description 5
- 210000003238 esophagus Anatomy 0.000 description 5
- 229940069949 propolis Drugs 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 208000009043 Chemical Burns Diseases 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- PWSZSZJBVQXJIX-IKHZIZRMSA-N (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol 2-methylnaphthalene-1,4-dione (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol Chemical compound CC1=CC(=O)c2ccccc2C1=O.C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C.CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1 PWSZSZJBVQXJIX-IKHZIZRMSA-N 0.000 description 3
- 235000019737 Animal fat Nutrition 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 206010013642 Drooling Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000008630 Sialorrhea Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- -1 AEKOL vitamin Chemical class 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010006707 Burn oesophageal Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 229940031955 anhydrous lanolin Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 231100000045 chemical toxicity Toxicity 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 229940042125 oral ointment Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Группа изобретений относится к медицине, а именно к фармакологии и хирургии, и может быть использована при производстве мазей и для лечения всех стадий воспалительных заболеваний кожи, подкожной жировой клетчатки, мягких тканей, долгонезаживающих ран, трофических язв, флегмон, пролежней, ожогов кожи 1-4 степени, ожогов роговицы глаза, хронических заболеваний носа и придаточных пазух и для лечения некоторых внутренних болезней, например эрозии шейки матки, эрозивных гастритов, бульбитов, химических ожогов пищевода, желудка и др. Задачей данного изобретения является создания путем
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200815278A UA86565C2 (ru) | 2008-12-30 | 2008-12-30 | Универсальная биологическая мазь, способ лечения ожоговых ран и способ лечения химических ожогов пищевода |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200815278A UA86565C2 (ru) | 2008-12-30 | 2008-12-30 | Универсальная биологическая мазь, способ лечения ожоговых ран и способ лечения химических ожогов пищевода |
Publications (1)
Publication Number | Publication Date |
---|---|
UA86565C2 true UA86565C2 (ru) | 2009-04-27 |
Family
ID=50620104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200815278A UA86565C2 (ru) | 2008-12-30 | 2008-12-30 | Универсальная биологическая мазь, способ лечения ожоговых ран и способ лечения химических ожогов пищевода |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA86565C2 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2705392C1 (ru) * | 2019-07-19 | 2019-11-07 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Глазная мазь на основе 6-метил-3-(тиетан-3-ил)урацила с ранозаживляющим эффектом |
-
2008
- 2008-12-30 UA UAA200815278A patent/UA86565C2/ru unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2705392C1 (ru) * | 2019-07-19 | 2019-11-07 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Глазная мазь на основе 6-метил-3-(тиетан-3-ил)урацила с ранозаживляющим эффектом |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101991688A (zh) | 药物组合物在制备治疗糖尿病溃疡药物中的用途 | |
ES2901419T3 (es) | Medicamento tópico para lesiones de la piel y las mucosas asociadas con epidermólisis ampollosa | |
CN101332271A (zh) | 一种治疗烧烫伤的外用药物组合物 | |
UA86565C2 (ru) | Универсальная биологическая мазь, способ лечения ожоговых ран и способ лечения химических ожогов пищевода | |
RU2416425C1 (ru) | Масло противопролежневое | |
RU2433171C1 (ru) | Способ получения биологически активной субстанции из эмбрионально-яичной массы для приготовления противоожоговой пластины и противоожоговая пластина на его основе | |
CN104367906A (zh) | 一种治疗烧伤烫伤、酒糟鼻及痤疮的药物及其制备方法 | |
CN107961232A (zh) | 药物调配物和其用途 | |
RU2730889C2 (ru) | Способ проведения курса голодания для тяжелобольных пациентов | |
US20190110512A1 (en) | Food composition for relieving symptoms of viral diseases | |
CN108785530A (zh) | 一种液化生肌愈皮膏及其制备方法 | |
RU2128990C1 (ru) | Мазь противовоспалительная и ранозаживляющая "вундэхил" | |
CN108210548A (zh) | 用于外伤创面的中药药膏及其制备方法 | |
Walsham | Surgery: its theory and practice | |
RU2478368C2 (ru) | Мазь для лечения при обморожениях | |
Khalilzadeh | Treatment of Umbilical Pilonidal Sinus Based on Persian Medicine Principles: A Case Report | |
RU2156131C1 (ru) | Полуфабрикат для получения основы лекарственного средства, основы лекарственного средства из этого полуфабриката (варианты) и лекарственное средство на этой основе (варианты) | |
CN105708995A (zh) | 竭獾溃疡油制备方法 | |
Urman et al. | Diagnosing Leishmaniasis in the Chronic Pain Management Setting: A Case Study | |
Anpuchelvy et al. | Case series of karam (kshara/corrosive gauze) application on Chronic ulcers | |
CN102670655B (zh) | 治疗烧烫伤的外用再生修复药物组合物 | |
JP2024511401A (ja) | 慢性皮膚潰瘍の予防または治療方法及び漢方薬組成物の薬物製造における使用 | |
CN116370516A (zh) | 一种治疗黑红伤及感染类疾病的膏药 | |
CN112791143A (zh) | 一种止血生肌药物 | |
Liang et al. | Skin symptoms |